PTC Therapeutics, Inc. · 20 hours ago
Associate Director, Statistical Programming
Maximize your interview chances
BiotechnologyHealth Care
Comp. & BenefitsH1B Sponsor Likely
Insider Connection @PTC Therapeutics, Inc.
Get 3x more responses when you reach out via email instead of LinkedIn.
Responsibilities
Leads the statistical programming project team (including Clinical Research Organization (CRO) oversight as necessary) in support of clinical development programs in the assigned therapeutic areas.
Ensures timely statistical analyses of clinical data per protocols and Statistical Analysis Plans; develops statistical programs and produces programmed outputs used to create integrated scientific reports for clinical trial results.
Participates in study team meetings as a representative of the Biostatistics function. Communicates statistical issues and acts as a statistical/programming resource to the development teams.
Participates in the assessment, selection and evaluation of CROs
Interacts with CROs involved in data management/analysis activities to ensure that their statistical analyses and resulting outputs are accurate and consistent with the contractually agreed upon deliverables; works with vendor staff to characterize and resolve issues related to data analysis.
Creates/Reviews derived dataset specifications and the related analysis datasets.
Manages internal contractors and junior programmers and provides mentorship as needed.
Develops SOPs and training guidelines related to statistical programming.
Performs other tasks and assignments as needed and specified by management.
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
Master’s degree in a quantitative sciences discipline (e.g., Statistics, Mathematics, Computer Science) and a minimum of 7 years of progressively responsible experience in statistics or statistical programming in a pharmaceutical, biotechnology, CRO or related environment OR a Bachelor’s degree in a quantitative sciences discipline (e.g., Statistics, Mathematics, Computer Science) and a minimum of 9 years of progressively responsible experience in statistics or statistical programming in a pharmaceutical, biotechnology, CRO or related environment
Demonstrated and applied SAS programming skills (e.g., Base SAS, SAS/Stat, SAS/Graph, SAS macros, ODS) and a good understanding of database systems
Working knowledge of R
Expertise in the implementation of Clinical Data Interchange Standards Consortium (CDISC) standards
Applied knowledge of clinical data analysis and reporting processes as related to drug development
Proficiency with Microsoft Office
Excellent verbal and written communication and skills
Ability to work independently and collaboratively, as required, in a fast-paced, matrixed, team environment consisting of internal and external team members
Analytical thinker with excellent problem-solving skills and the ability to adapt to changing priorities and deadlines
Excellent planning, organization and time management skills including the ability to support and prioritize multiple projects
Preferred
Experience working directly with CROs
Experience supporting New Drug Applications (NDAs) and Marketing Authorisation Applications (MAAs) submissions
Benefits
Short- and long-term incentives
Medical, dental, vision, and retirement savings plans
Company
PTC Therapeutics, Inc.
PTC is a science-driven, patient-centered biopharmaceutical company focused on discovering, developing & commercializing medicine for patients with rare and serious disease.
H1B Sponsorship
PTC Therapeutics, Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2023 (10)
2022 (31)
2021 (12)
2020 (8)
Funding
Current Stage
Public CompanyTotal Funding
$1.57BKey Investors
Brookside CapitalCredit Suisse First Boston
2022-10-27Post Ipo Equity· $1B
2020-05-14Post Ipo Equity· $140.95M
2015-08-14Post Ipo Debt· $150M
Recent News
2024-11-15
2024-11-15
Company data provided by crunchbase